Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0DQLFD
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
GQ-1010
|
|||||
| Synonyms |
GQ 1010; GQ-1010; GQ1010
Click to Show/Hide
|
|||||
| Organization |
GeneQuantum Healthcare (Suzhou) Co. Ltd.
|
|||||
| Drug Status |
Phase 1/2
|
|||||
| Indication |
In total 1 Indication(s)
|
|||||
| Drug-to-Antibody Ratio |
Undisclosed
|
|||||
| Antibody Name |
Undisclosed
|
|||||
| Antigen Name |
Tumor-associated calcium signal transducer 2 (TROP2)
|
Antigen Info | ||||
| Payload Name |
Camptothecin analogue
|
Payload Info | ||||
| Therapeutic Target |
DNA topoisomerase 1 (TOP1)
|
Target Info | ||||
| Conjugate Type |
Reactive Cysteines
|
|||||
